Abstract
As with all clinical trials, clinical trials in the epilepsies must, of necessity, be designed to deal with certain peculiarities of the disorder. The first important concept in the design of trials is the recognition that many different syndromes are included in the epilepsies and that meaningful data cannot be collected from an undifferentiated group of epileptic persons. Fortunately, very empirical information — the clinical seizure type — has rather good correlation with the various therapeutic measures and seizure classifications [2]. These data are useful as a first step in obtaining some form of homogeneity among the patients to be studied. This brief summary will concentrate on variables important in the clinical trials of new antiepileptic drugs; even though clinical trials of other therapeutic modalities (such as biofeedback or surgery) are quite important and remain in a relatively primitive state of development, most persons with epilepsy are treated with antiepileptic drugs, and most patients who remain uncontrolled on drugs are hopeful for the development of new, less toxic, and more effective medications. This communication will also be limited to a discussion of controlled clinical trials of antiepileptic drugs, in children and adults, exclusive of infantile spasms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cereghino JJ, Penry JK (1982) Testing of antiepileptic drugs in humans: clinical considerations. In: Woodbury DM, Penry JK, Pippinger CE (ed) Antiepileptic drugs. Raven, New York
Dreifuss FE (1985) The medical management of partial and generalized tonic-clonic seizures. In: Porter RJ, Morselli PL (ed) The epilepsies. Butterworths, London
Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. Engl J Med 313: 145–151
Porter RJ (1984) Epilepsy: 100 Elementary principles. Saunders, London
Porter RJ (1985) Intensive monitoring: epileptic and non-epileptic seizures. In: Porter RJ, Morselli PL (ed) The epilepsies. Butterworths, London
Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG (1984) Antiepileptic drug development program. Cleve Clin Q Summer 1984: 293–305
Sato S, White BG, Penry JK, Dreifuss FE, Sachellares JC, Kupferberg HJ (1982) Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology (Minn) 32: 157–163
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Porter, R.J. (1986). Clinical Trials Relating to Epilepsy. In: Poeck, K., Freund, HJ., Gänshirt, H. (eds) Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70007-1_43
Download citation
DOI: https://doi.org/10.1007/978-3-642-70007-1_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70009-5
Online ISBN: 978-3-642-70007-1
eBook Packages: Springer Book Archive